1. Home
  2. SNSE vs SQFT Comparison

SNSE vs SQFT Comparison

Compare SNSE & SQFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SNSE
  • SQFT
  • Stock Information
  • Founded
  • SNSE 2005
  • SQFT 1999
  • Country
  • SNSE United States
  • SQFT United States
  • Employees
  • SNSE N/A
  • SQFT N/A
  • Industry
  • SNSE Biotechnology: Pharmaceutical Preparations
  • SQFT Real Estate Investment Trusts
  • Sector
  • SNSE Health Care
  • SQFT Real Estate
  • Exchange
  • SNSE Nasdaq
  • SQFT Nasdaq
  • Market Cap
  • SNSE 9.3M
  • SQFT 8.1M
  • IPO Year
  • SNSE 2021
  • SQFT 2020
  • Fundamental
  • Price
  • SNSE $0.34
  • SQFT $0.61
  • Analyst Decision
  • SNSE Strong Buy
  • SQFT
  • Analyst Count
  • SNSE 4
  • SQFT 0
  • Target Price
  • SNSE $4.25
  • SQFT N/A
  • AVG Volume (30 Days)
  • SNSE 111.9K
  • SQFT 25.2K
  • Earning Date
  • SNSE 05-06-2025
  • SQFT 05-14-2025
  • Dividend Yield
  • SNSE N/A
  • SQFT N/A
  • EPS Growth
  • SNSE N/A
  • SQFT N/A
  • EPS
  • SNSE N/A
  • SQFT N/A
  • Revenue
  • SNSE N/A
  • SQFT $18,260,398.00
  • Revenue This Year
  • SNSE N/A
  • SQFT $23.63
  • Revenue Next Year
  • SNSE N/A
  • SQFT N/A
  • P/E Ratio
  • SNSE N/A
  • SQFT N/A
  • Revenue Growth
  • SNSE N/A
  • SQFT N/A
  • 52 Week Low
  • SNSE $0.25
  • SQFT $0.47
  • 52 Week High
  • SNSE $1.94
  • SQFT $0.94
  • Technical
  • Relative Strength Index (RSI)
  • SNSE 41.60
  • SQFT 46.32
  • Support Level
  • SNSE $0.32
  • SQFT $0.59
  • Resistance Level
  • SNSE $0.38
  • SQFT $0.65
  • Average True Range (ATR)
  • SNSE 0.03
  • SQFT 0.03
  • MACD
  • SNSE -0.00
  • SQFT -0.00
  • Stochastic Oscillator
  • SNSE 21.49
  • SQFT 25.00

About SNSE Sensei Biotherapeutics Inc.

Sensei Biotherapeutics Inc is an immuno-oncology company focused on the discovery and development of next-generation therapeutics for cancer patients. Its TMAb (Tumor Microenvironment Activated Biologics) platform developing selective therapeutics designed to disable immunosuppressive signals or activate immunostimulatory signals selectively in the tumor microenvironment. The company have four investigational product candidates in various stages of development: SNS-101 (VISTA), SNS-102 (VSIG4 ), SNS-103 (ENTPDase/CD39), SNS-201 (VISTAxCD28).

About SQFT Presidio Property Trust Inc.

Presidio Property Trust Inc is an internally managed, diversified REIT with holdings in model home properties which are triple-net leased to homebuilders, office, industrial, and retail properties. Presidio's model homes are leased to homebuilders located in Arizona, Illinois, Texas, Wisconsin, and Florida. The office, industrial and retail properties are located primarily in Colorado, with properties also located in Maryland, North Dakota, Texas, and Southern California.

Share on Social Networks: